Download PDF
Planta Med 2014; 80(12): 1045-1050
DOI: 10.1055/s-0034-1382907
Biological Screening
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Natural Products as Potential Human Ether-a-Go-Go-Related Gene Channel Inhibitors – Outcomes from a Screening of Widely Used Herbal Medicines and Edible Plants

Anja Schramm
1   Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
,
Evelyn A. Jähne
1   Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
,
Igor Baburin
2   Institute of Pharmacology and Toxicology, University of Vienna, Vienna, Austria
,
Steffen Hering
2   Institute of Pharmacology and Toxicology, University of Vienna, Vienna, Austria
,
Matthias Hamburger
1   Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
› Author Affiliations
Further Information

Publication History

received 27 February 2014
revised 25 June 2014

accepted 30 June 2014

Publication Date:
04 August 2014 (online)

    Permissions and Reprints

Abstract

Inhibition of the human ether-a-go-go-related gene channel is the single most important risk factor leading to acquired long QT syndrome. Drug-induced QT prolongation can cause severe cardiac complications, including arrhythmia, and is thus a liability in drug development. Considering the importance of the human ether-a-go-go-related gene channel as an antitarget and the daily intake of plant-derived foods and herbal products, surprisingly few natural products have been tested for channel blocking properties. In an assessment of possible human ether-a-go-go-related gene liabilities, a selection of widely used herbal medicines and edible plants (vegetables, fruits, and spices) was screened by means of a functional two-microelectrode voltage-clamp assay with Xenopus oocytes. The human ether-a-go-go-related gene channel blocking activity of selected extracts was investigated with the aid of a high-performance liquid chromatography-based profiling approach, and attributed to tannins and alkaloids. Major European medicinal plants and frequently consumed food plants were found to have a low risk for human ether-a-go-go-related gene toxicity.

Key words

herbal drugs - dietary plants - hERG channel inhibition - Xenopus oocyte assay - HPLC-based activity profiling - alkaloids

Supporting Information

 

  • References

  • 1 De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Safety 2002; 25: 263-286
    CrossrefPubMedGoogle Scholar
  • 2 Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 2006; 440: 463-469
    CrossrefPubMedGoogle Scholar
  • 3 Blumenthal M, Lindstrom A, Ooyen C, Lynch ME. Herb supplement sales increase 4.5 % in 2011. HerbalGram 2012; 95: 60-64
    PubMedGoogle Scholar
  • 4 Biesalski HK. Nutraceuticals: the link between nutrition and medicine. J Toxicol Cutan Ocul Toxicol 2002; 21: 9-30
    CrossrefPubMedGoogle Scholar
  • 5 Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med 2004; 50: 145-149
    PubMedGoogle Scholar
  • 6 Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002; 113: 71S-88S
    CrossrefPubMedGoogle Scholar
  • 7 WHO. Technical report series 916: Diet, nutrition and the prevention of chronic diseases – Report of a joint WHO/FAO expert consultation. Geneva, Switzerland: WHO; 2003
    Google Scholar
  • 8 Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79: 727-747
    PubMedGoogle Scholar
  • 9 Ames BN. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983; 221: 1256-1264
    CrossrefPubMedGoogle Scholar
  • 10 Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. Johnʼs wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136: 42-53
    CrossrefPubMedGoogle Scholar
  • 11 Singh D, Gupta R, Saraf SA. Herbs – are they safe enough? An overview. Crit Rev Food Sci 2012; 52: 876-898
    CrossrefPubMedGoogle Scholar
  • 12 Zitron E, Scholz E, Owen RW, Lück S, Kiesecker C, Thomas D, Kathöfer S, Niroomand F, Kiehn J, Kreye VAW, Katus HA, Schoels W, Karle CA. QTc prolongation by grapefruit juice and its potential pharmacological basis: hERG channel blockade by flavonoids. Circulation 2005; 111: 835-838
    CrossrefPubMedGoogle Scholar
  • 13 Liu Y, Xu XH, Liu Z, Du XL, Chen KH, Xin X, Jin ZD, Shen JZ, Hu Y, Li GR, Jin MW. Effects of the natural flavone trimethylapigenin on cardiac potassium currents. Biochem Pharmacol 2012; 84: 498-506
    CrossrefPubMedGoogle Scholar
  • 14 Hu CW, Sheng Y, Zhang Q, Liu HB, Xie X, Ma WC, Huo R, Dong DL. Curcumin inhibits hERG potassium channels in vitro . Toxicol Lett 2012; 208: 192-196
    CrossrefPubMedGoogle Scholar
  • 15 Jeong I, Choi BH, Hahn SJ. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5. Pflug Arch Eur J Phy 2010; 460: 851-862
    CrossrefPubMedGoogle Scholar
  • 16 Harmati G, Papp F, Szentandrássy N, Bárándi L, Ruzsnavszky F, Horváth B, Bányász T, Magyar J, Panyi G, Krasznai Z, Nánási PP. Effects of the PKC inhibitors chelerythrine and bisindolylmaleimide I (GF 109203X) on delayed rectifier K+ currents. N – S Arch Pharmacol 2011; 383: 141-148
    PubMedGoogle Scholar
  • 17 Kim YJ, Hong HK, Lee HS, Moh SH, Park JC, Jo SH, Choe H. Papaverine, a vasodilator, blocks the pore of the hERG channel at submicromolar concentration. J Cardiovasc Pharm 2008; 52: 485-493
    CrossrefPubMedGoogle Scholar
  • 18 Xing JL, Ma JH, Zhang PH, Fan XR. Block effect of capsaicin on hERG potassium currents is enhanced by S6 mutation at Y652. Eur J Pharmacol 2010; 630: 1-9
    CrossrefPubMedGoogle Scholar
  • 19 Piccirillo G, Magrì D, Matera S, Magnanti M, Pasquazzi E, Schifano E, Velitti S, Mitra M, Marigliano V, Paroli M, Ghiselli A. Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects. Transl Res 2008; 151: 267-272
    CrossrefPubMedGoogle Scholar
  • 20 Potterat O, Hamburger M. Concepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with bioassays. Nat Prod Rep 2013; 30: 546-564
    CrossrefPubMedGoogle Scholar
  • 21 Jones WP, Kinghorn AD. Extraction of plant secondary metabolites. In: Sarker SD, Latif Z, Gray AI, editors Natural products isolation. 2nd edition. Totowa, New Jersey: Humana Press Inc.; 2005: 323-351
    CrossrefGoogle Scholar
  • 22 Saura-Calixto F, Pérez-Jiménez J. Tannins: bioavailability and mechanisms of action. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C, editors Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH GmbH & Co. KGaA; 2009: 499-508
    CrossrefGoogle Scholar
  • 23 Rasmussen SE, Frederiksen H, Struntze Krogholm K, Poulsen L. Dietary proanthocyanidins: Occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res 2005; 49: 159-174
    CrossrefPubMedGoogle Scholar
  • 24 Schulz JM, Herrmann K. Occurrence of catechins and proanthocyanidins in spices. V. Phenolics of spices. Z Lebensm Unters For 1980; 171: 278-280
    CrossrefPubMedGoogle Scholar
  • 25 Hellström JK, Törrönen AR, Mattila PH. Proanthocyanidins in common food products of plant origin. J Agr Food Chem 2009; 57: 7899-7906
    CrossrefPubMedGoogle Scholar
  • 26 Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, Prior RL. Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J Agr Food Chem 2003; 51: 7513-7521
    CrossrefPubMedGoogle Scholar
  • 27 Zaugg J, Baburin I, Strommer B, Kim HJ, Hering S, Hamburger M. HPLC-based activity profiling: discovery of piperine as a positive GABAA receptor modulator targeting a benzodiazepine-independent binding site. J Nat Prod 2010; 73: 185-191
    CrossrefPubMedGoogle Scholar
  • 28 Friedman M, Levin CE, Lee SU, Lee JS, Ohnisi-Kameyama M, Kozukue N. Analysis by HPLC and LC/MS of pungent piperamides in commercial black, white, green, and red whole and ground peppercorns. J Agr Food Chem 2008; 56: 3028-3036
    CrossrefPubMedGoogle Scholar
  • 29 Khom S, Strommer B, Schöffmann A, Hintersteiner J, Baburin I, Erker T, Schwarz T, Schwarzer C, Zaugg J, Hamburger M, Hering S. GABAA receptor modulation by piperine and a non-TRPV1 activating derivative. Biochem Pharmacol 2013; 85: 1827-1836
    CrossrefPubMedGoogle Scholar
  • 30 Schramm A, Baburin I, Hering S, Hamburger M. hERG channel inhibitors in extracts of Coptidis rhizoma. Planta Med 2011; 77: 692-697
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Rampe D, Brown AM. A history of the role of the hERG channel in cardiac risk assessment. J Pharmacol Toxicol Methods 2013; 68: 13-22
    CrossrefPubMedGoogle Scholar
  • 32 Spinozzi S, Colliva C, Camborata C, Roberti M, Ianni C, Neri F, Calvarese C, Lisotti A, Mazzella G, Roda A. Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects. J Nat Prod 2014; DOI: 10.1021/np400607k.
    PubMedGoogle Scholar
  • 33 Basalo C, Mohn T, Hamburger M. Are extraction methods in quantitative assays of pharmacopoeia monographs exhaustive? A comparison with pressurized liquid extraction. Planta Med 2006; 72: 1157-1162
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Benthin B, Danz H, Hamburger M. Pressurized liquid extraction of medicinal plants. J Chromatogr A 1999; 837: 211-219
    CrossrefPubMedGoogle Scholar
  • 35 Baburin I, Beyl S, Hering S. Automated fast perfusion of Xenopus oocytes for drug screening. Pflug Arch Eur J Phy 2006; 453: 117-123
    CrossrefPubMedGoogle Scholar
  • 36 Stork D, Timin EN, Berjukow S, Huber C, Hohaus A, Auer M, Hering S. State dependent dissociation of hERG channel inhibitors. Brit J Pharmacol 2007; 151: 1368-1376
    PubMedGoogle Scholar